Suppr超能文献

人类细胞中 DNA 聚合酶 zeta 的低保真变体导致易错旁路修复。

Error-prone bypass patch by a low-fidelity variant of DNA polymerase zeta in human cells.

机构信息

Division of Genetics and Mutagenesis, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa, 210-9501, Japan.

Division of Genetics and Mutagenesis, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa, 210-9501, Japan.

出版信息

DNA Repair (Amst). 2021 Apr;100:103052. doi: 10.1016/j.dnarep.2021.103052. Epub 2021 Feb 3.

Abstract

DNA polymerase ζ (Pol ζ) is a specialized Pol that is involved in translesion DNA synthesis (TLS), in particular, in the extension of primer DNA after bypassing DNA lesions. Previously, we established human cells that express a variant form of Pol ζ with an amino acid change of leucine 2618 to methionine (L2618M) in the catalytic subunit REV3L (DNA Repair, 45, 34-43, 2016). This amino acid change made the cells more sensitive to the mutagenicity of benzo[a]pyrene diol epoxide (BPDE). In this study, we embedded BPDE-N-guanine at a defined position in the supF gene on the shuttle plasmid and introduced it to REV3 L2618M cells or the wild-type (WT) cells to examine how far Pol ζ L2618M extends the primer DNA after bypassing the lesion. The adduct induced primarily G to T and G to C at the adducted site in both cell lines, but generated additional sequence changes such as base substitutions, deletions and additions in the extension patch much more often in REV3 L2618M cells than in the WT cells. Mutations in the extension patch in REV3 L2618M cells occurred most often within 10 bps from the adducted site. Then, the number of mutations gradually decreased and no mutations were observed between 30 and 40 bps from the lesion. We concluded that human Pol ζ L2618M and perhaps WT Pol ζ extend the primer DNA up to approximately 30 bps from the lesion in vivo. The possibility of involvement of Pol ζ L2618M in the insertion step of TLS is discussed.

摘要

DNA 聚合酶 ζ(Pol ζ)是一种专门的聚合酶,参与跨损伤 DNA 合成(TLS),特别是在绕过 DNA 损伤后延伸引物 DNA。此前,我们建立了表达具有催化亚基 REV3L 中氨基酸改变亮氨酸 2618 为蛋氨酸(L2618M)的变体形式 Pol ζ的人细胞(DNA 修复,45,34-43,2016)。这种氨基酸改变使细胞对苯并[a]芘二醇环氧化物(BPDE)的致突变性更敏感。在这项研究中,我们将 BPDE-N-鸟嘌呤嵌入穿梭质粒上 supF 基因的一个确定位置,并将其引入 REV3 L2618M 细胞或野生型(WT)细胞中,以检查 Pol ζ L2618M 在绕过损伤后延伸引物 DNA 的程度。在这两种细胞系中,加合物主要在加合物部位诱导 G 到 T 和 G 到 C 的转换,但在 REV3 L2618M 细胞中比在 WT 细胞中更频繁地产生额外的序列变化,如碱基取代、缺失和添加在延伸补丁中。REV3 L2618M 细胞中延伸补丁中的突变最常发生在加合物部位附近的 10 个碱基对内。然后,突变的数量逐渐减少,在损伤处 30 到 40 个碱基对之间没有观察到突变。我们得出结论,人类 Pol ζ L2618M 甚至 WT Pol ζ 在体内从损伤处延伸引物 DNA 约 30 个碱基对。讨论了 Pol ζ L2618M 参与 TLS 插入步骤的可能性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验